Why is adrenaline (epinephrine) administered during a second shock in cardiac arrest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Epinephrine in Shockable Cardiac Arrest Rhythms

For cardiac arrest with shockable rhythms (VF/pVT), epinephrine should be administered after initial defibrillation attempts have failed, typically after the second or third shock, because the priority is immediate defibrillation and high-quality CPR, with epinephrine playing a secondary role once electrical therapy proves unsuccessful. 1, 2, 3

The Rationale: Rhythm-Specific Strategy

The timing of epinephrine differs fundamentally based on the initial cardiac rhythm:

For Shockable Rhythms (VF/pVT):

  • Defibrillation takes priority over medication administration, as electrical therapy is the definitive treatment for ventricular fibrillation and pulseless ventricular tachycardia 1
  • The American Heart Association provides only a Class 2b (weak) recommendation for epinephrine timing in shockable rhythms, acknowledging insufficient evidence for optimal timing in relation to defibrillation 1, 3
  • Pediatric guidelines specifically state: administer epinephrine during CPR after the second shock (4 J/kg), continuing every 3-5 minutes thereafter 1

For Non-Shockable Rhythms (PEA/Asystole):

  • Epinephrine should be given as soon as feasible after establishing vascular access (Class 2a recommendation) 1, 2, 3
  • This represents a fundamentally different approach because these rhythms cannot be defibrillated 4

The Physiologic Mechanism

Why Epinephrine Works:

  • Alpha-adrenergic effects increase coronary perfusion pressure (aortic diastolic pressure minus right atrial pressure), which is the critical mechanism for restoring spontaneous circulation 5
  • Epinephrine significantly increases ROSC rates by 151 more patients per 1,000 compared to placebo (RR 2.80,95% CI 1.78-4.41) 2
  • It increases survival to hospital admission by 124 more patients per 1,000 (RR 1.95% CI 1.34-2.84) 2

Why Timing Matters in Shockable Rhythms:

  • Beta-adrenergic stimulation increases myocardial oxygen consumption in fibrillating myocardium, which is potentially deleterious 5
  • The heart needs to be defibrillated first; giving epinephrine before attempting defibrillation may complicate the electrical therapy without providing benefit 1
  • CPR provides coronary perfusion that increases the likelihood of successful defibrillation with subsequent shocks 1

The Practical Algorithm for Shockable Rhythms

Initial Management (First 4-6 Minutes):

  1. Immediate defibrillation at 2 J/kg (pediatric) or appropriate adult dose 1
  2. Resume CPR immediately for 2 minutes after shock delivery 1
  3. Second shock at 4 J/kg (pediatric) or appropriate adult dose if shockable rhythm persists 1
  4. Resume CPR immediately for 2 minutes 1

After Failed Initial Defibrillation Attempts:

  • Administer epinephrine 1 mg IV/IO (0.01 mg/kg in pediatrics, max 1 mg) during chest compressions 1, 2
  • Repeat every 3-5 minutes throughout the resuscitation 1, 2
  • Consider antiarrhythmics (amiodarone or lidocaine) after the third shock 1

Evidence Quality and Controversies

The Evidence Gap:

  • There is insufficient evidence to make a strong recommendation regarding optimal epinephrine timing in shockable rhythms, particularly in relation to defibrillation 1
  • The relationship between timing of defibrillation and timing of epinephrine remains unknown in studies of shockable rhythms 1
  • Most observational studies have significant design flaws, including inability to determine the precise relationship between defibrillation attempts and epinephrine administration 1

The Neurological Outcome Concern:

  • While epinephrine increases ROSC and short-term survival, its effect on favorable neurological outcomes remains uncertain 3, 6, 7
  • The American Heart Association acknowledges the fundamental challenge in determining the likelihood of favorable versus unfavorable neurological outcome at the time of arrest 2
  • Some evidence suggests epinephrine may not provide meaningful neurological recovery despite improving survival rates 6, 7

Critical Pitfalls to Avoid

Common Errors:

  • Do not delay defibrillation to administer epinephrine in shockable rhythms 1
  • Minimize interruptions in chest compressions - epinephrine should be administered during ongoing compressions, not as a reason to pause CPR 1
  • Do not use high-dose epinephrine (>1 mg in adults, >0.01 mg/kg in pediatrics) routinely, as it increases ROSC but does not improve survival or neurological outcomes and may be harmful 1, 2, 3
  • Avoid confusing shockable and non-shockable protocols - the timing strategy is fundamentally different 1, 2, 3

Dosing Specifics:

  • Standard adult dose: 1 mg IV/IO every 3-5 minutes 2, 3
  • Pediatric dose: 0.01 mg/kg (0.1 mL/kg of 1:10,000 concentration), maximum 1 mg 1
  • No maximum cumulative dose is defined, though doses above 3 mg may be associated with unfavorable neurological outcomes 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Epinephrine Administration in Pre-Hospital Cardiac Arrest

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Role of Epinephrine in Cardiopulmonary Resuscitation (CPR)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The role of epinephrine in CPR: a reappraisal.

Annals of emergency medicine, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.